Fluorine F 18 Piflufolastat

OTHER2 trials

Sponsors

City of Hope Medical Center, Northwestern University

Conditions

Prostate AdenocarcinomaProstate Carcinoma

Phase 2

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

RecruitingNCT06499870

Northwestern UniversityProstate Adenocarcinoma

Start: 2024-09-06End: 2032-11-19Target: 50Updated: 2025-10-21

Unknown Phase

RefleXion PET/CT Imaging Performance in Patients With Prostate Cancer

Active, not recruitingNCT05470699

City of Hope Medical CenterProstate Carcinoma

Start: 2022-08-29End: 2026-04-13Updated: 2025-12-17